Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy
LEUKEMIA & LYMPHOMA (2012)
期刊
LEUKEMIA & LYMPHOMA
卷 53, 期 6, 页码 1057-1061出版社
INFORMA HEALTHCARE
关键词
作者
我是这篇论文的作者
推荐
Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Multiple Myeloma Based on Bone Marrow Homing
Ying Qu, Bingyang Chu, Xue Wei, Yingying Chen, Yun Yang, Danrong Hu, Jingcao Huang, Fangfang Wang, Mengran Chen, Yuhuan Zheng, Zhiyong Qian
ADVANCED MATERIALS (2022)
Bone/cartilage targeted hydrogel: Strategies and applications
Hao Zhang, Shunli Wu, Weikai Chen, Yan Hu, Zhen Geng, Jiacan Su
BIOACTIVE MATERIALS (2023)
GPRC5D-Targeted CAR T Cells for Myeloma
Sham Mailankody, Sean M. M. Devlin, Jonathan Landa, Karthik Nath, Claudia Diamonte, Elizabeth J. J. Carstens, Douglas Russo, Romany Auclair, Lisa Fitzgerald, Briana Cadzin, Xiuyan Wang, Devanjan Sikder, Brigitte Senechal, Vladimir P. P. Bermudez, Terence J. J. Purdon, Kinga Hosszu, Devin P. P. McAvoy, Tasmin Farzana, Elena Mead, Jessica A. A. Wilcox, Bianca D. D. Santomasso, Gunjan L. L. Shah, Urvi A. A. Shah, Neha Korde, Alexander Lesokhin, Carlyn R. R. Tan, Malin Hultcrantz, Hani Hassoun, Mikhail Roshal, Filiz Sen, Ahmet Dogan, Ola Landgren, Sergio A. A. Giralt, Jae H. H. Park, Saad Z. Z. Usmani, Isabelle Riviere, Renier J. J. Brentjens, Eric L. L. Smith
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma
Dennis Awuah, Megan Minnix, Enrico Caserta, Theophilus Tandoh, Vikram Adhikarla, Erasmus Poku, Russell Rockne, Flavia Pichiorri, John E. Shively, Xiuli Wang
CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)
Targeted Therapies for Multiple Myeloma
Christopher Chang-Yew Leow, Michael Sze Yuan Low
JOURNAL OF PERSONALIZED MEDICINE (2021)
Steps towards a Multiple Myeloma Cure?
Alessandro Gozzetti, Monica Bocchia
JOURNAL OF PERSONALIZED MEDICINE (2022)
Microenvironment-responsive nanocarriers for targeted bone disease therapy
Mengmeng Li, Biao Yu, Sicheng Wang, Fengjin Zhou, Jin Cui, Jiacan Su
NANO TODAY (2023)
CD38-targeted and erythrocyte membrane camouflaged nanodrug delivery system for photothermal and chemotherapy in multiple myeloma
Fangrong Zhang, Qin Yang, Sishi Tang, Siyi Jiang, Qiangqiang Zhao, Jian Li, Cong Xu, Jing Liu, Yunfeng Fu
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)
The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease
Oxana Lungu, Denise Toscani, Jessica Burroughs-Garcia, Nicola Giuliani
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Therapeutic Potential of Innate Lymphoid Cells for Multiple Myeloma Therapy
Aneta Szudy-Szczyrek, Sean Ahern, Magdalena Koziol, Daria Majowicz, Michal Szczyrek, Janusz Krawczyk, Marek Hus
CANCERS (2021)
Requirements for operational cure in multiple myeloma
Mohamad Mohty, Herve Avet-Loiseau, Jean-Luc Harousseau
BLOOD (2021)
An Improved Animal Model of Multiple Myeloma Bone Disease
Syed Hassan Mehdi, Carol A. Morris, Jung Ae Lee, Donghoon Yoon
CANCERS (2021)
Single-cell profiling in multiple myeloma: insights problems, and promises
Mehmet Kemal Samur, Raphael Szalat, Nikhil C. Munshi
BLOOD (2023)
89Zr-DFO-Isatuximab for CD38-Targeted ImmunoPET Imaging of Multiple Myeloma and Lymphomas
Natalia Herrero Alvarez, Alexa L. Michel, Tara D. Viray, Marius E. Mayerhoefer, Jason S. Lewis
ACS OMEGA (2023)
Bone-Targeted Bortezomib Inhibits Bortezomib-Resistant Multiple Myeloma in Mice by Providing Higher Levels of Bortezomib in Bone
Jianguo Tao, Venkat Srinivasan, Xiangjiao Yi, Yingchun Zhao, Hengwei Zhang, Xi Lin, Xichao Zhou, Brendan F. Boyce, Peter W. Villalta, Frank H. Ebetino, Koc Kan Ho, Robert K. Boeckman, Lianping Xing
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis
Zuzana Chyra, Tereza Sevikova, Petr Vojta, Janka Puterova, Lucie Brozova, Katerina Growkova, Jana Filipova, Martina Zatopkova, Sebastian Grosicki, Agnieszka Barchnicka, Wieslaw Wiktor-Jedrzejczak, Anna Waszczuk-Gajda, Alexandra Jungova, Aneta Mikulasova, Marian Hajduch, Martin Mokrejs, Ludek Pour, Martin Stork, Lubica Harvanova, Martin Mistrik, Gabor Mikala, Pawel Robak, Anna Czyz, Jakub Debski, Lidia Usnarska-Zubkiewicz, Artur Jurczyszyn, Lukas Stejskal, Gareth Morgan, Fedor Kryukov, Eva Budinska, Michal Simicek, Tomas Jelinek, Matous Hrdinka, Roman Hajek
HAEMATOLOGICA (2021)
Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma
Ceri Bygrave, Charlotte Pawlyn, Faith Davies, Zoe Craig, David Cairns, Anna Hockaday, Matthew Jenner, Gordon Cook, Mark Drayson, Roger Owen, Walter Gregory, Gareth Morgan, Graham Jackson, Martin Kaiser
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial
Graham H. Jackson, Charlotte Pawlyn, David A. Cairns, Alina Striha, Corinne Collett, Anna Waterhouse, John R. Jones, Jamie Wilson, Craig Taylor, Bhuvan Kishore, Mamta Garg, Cathy D. Williams, Kamaraj Karunanithi, Jindriska Lindsay, Matthew W. Jenner, Gordon Cook, Nigel H. Russell, Mark T. Drayson, Martin F. Kaiser, Roger G. Owen, Walter M. Gregory, Faith E. Davies, Gareth J. Morgan
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Designing Evolutionary-based Interception Strategies to Block the Transition from Precursor Phases to Multiple Myeloma
Francesco Maura, Ola Landgren, Gareth J. Morgan
CLINICAL CANCER RESEARCH (2021)
Autologous stem cell transplantation is safe and effective for fit, older myeloma patients: exploratory results from the Myeloma XI trial
Charlotte Pawlyn, David A. Cairns, Tom Menzies, John R. Jones, Matthew W. Jenner, Gordon Cook, Kevin D. Boyd, Mark T. Drayson, Martin F. Kaiser, Roger G. Owen, Walter Gregory, Gareth J. Morgan, Graham H. Jackson, Faith E. Davies
HAEMATOLOGICA (2022)
From Bench to Bedside The Evolution of Genomics and Its Implications for the Current and Future Management of Multiple Myeloma
Gareth J. Morgan, Eileen M. Boyle, Faith E. Davies
CANCER JOURNAL (2021)
Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial
Sarah Bird, David Cairns, Tom Menzies, Kevin Boyd, Faith Davies, Gordon Cook, Mark Drayson, Walter Gregory, Matthew Jenner, John Jones, Martin Kaiser, Roger Owen, Graham Jackson, Gareth Morgan, Charlotte Pawlyn
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: results from a multicenter, phase II, randomized, controlled trial (MUKfive)
Kwee L. Yong, Samantha Hinsley, Holger W. Auner, Ceri Bygrave, Martin F. Kaiser, Karthik Ramasamy, Ruth M. de Tute, Debbie Sherratt, Louise Flanagan, Mamta Garg, Stephen Hawkins, Catherine Williams, Jamie Cavenagh, Neil K. Rabin, James Croft, Gareth Morgan, Faith Davies, Roger G. Owen, Sarah R. Brown
HAEMATOLOGICA (2021)
The mutagenic impact of melphalan in multiple myeloma
Francesco Maura, Niels Weinhold, Benjamin Diamond, Dickran Kazandjian, Leo Rasche, Gareth Morgan, Ola Landgren
LEUKEMIA (2021)
Chromothripsis as a pathogenic driver of multiple myeloma
Francesco Maura, Eileen M. Boyle, Even H. Rustad, Cody Ashby, David Kaminetzky, Benedetto Bruno, Marc Braunstein, Michael Bauer, Patrick Blaney, Yubao Wang, Hussein Ghamlouch, Louis Williams, James Stoeckle, Faith E. Davies, Brian A. Walker, Kylee Maclachlan, Ben Diamond, Ola Landgren, Gareth J. Morgan
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2022)
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
Benedith Oben, Guy Froyen, Kylee H. Maclachlan, Daniel Leongamornlert, Federico Abascal, Binbin Zheng-Lin, Venkata Yellapantula, Andriy Derkach, Ellen Geerdens, Benjamin T. Diamond, Ingrid Arijs, Brigitte Maes, Kimberly Vanhees, Malin Hultcrantz, Elisabet E. Manasanch, Dickran Kazandjian, Alexander Lesokhin, Ahmet Dogan, Yanming Zhang, Aneta Mikulasova, Brian Walker, Gareth Morgan, Peter J. Campbell, Ola Landgren, Jean-Luc Rummens, Niccolo Bolli, Francesco Maura
NATURE COMMUNICATIONS (2021)
A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma
Kwan Yeung Wong, Gareth J. Morgan, Eileen M. Boyle, Alfred Sze Lok Cheng, Kevin Yuk-Lap Yip, Chor Sang Chim
SCIENTIFIC REPORTS (2021)
Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
Eileen M. Boyle, Louis Williams, Patrick Blaney, Cody Ashby, Michael Bauer, Brian A. Walker, Hussein Ghamlouch, Jinyoung Choi, Emeline Perrial, Yubao Wang, Jessica Caro, James H. Stoeckle, Arnaldo Arbini, David Kaminetzky, Marc Braunstein, Benedetto Bruno, Beatrice Razzo, Benjamin Diamond, Kylee Maclachlan, Francesco Maura, Ola Landgren, Rachel Litke, Christopher D. Fegan, Johnathan Keats, Daniel Auclair, Faith E. Davies, Gareth J. Morgan
LEUKEMIA (2022)
Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients
Jessica Caro, Marc Braunstein, Louis Williams, Benedetto Bruno, David Kaminetzky, Ariel Siegel, Beatrice Razzo, Serge Alfandari, Gareth J. Morgan, Faith E. Davies, Eileen M. Boyle
LEUKEMIA (2022)
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
Mark A. Dawson, Gautam Borthakur, Brian J. P. Huntly, Anastasios Karadimitris, Adrian Alegre, Aristeidis Chaidos, Dan T. Vogl, Daniel A. Pollyea, Faith E. Davies, Gareth J. Morgan, Jacob L. Glass, Manali Kamdar, Maria -Victoria Mateos, Natalia Tovar, Paul Yeh, Regina Garcia Delgado, Faisal Basheer, Ludovica Marando, Paolo Gallipoli, Anastasia Wyce, Anu Shilpa Krishnatry, Olena Barbash, Evi Bakirtzi, Geraldine Ferron-Brady, Natalie O. Karpinich, Michael T. McCabe, Shawn W. Foley, Thierry Horner, Arindam Dhar, Brandon E. Kremer, Michael Dickinson
CLINICAL CANCER RESEARCH (2023)